OXT and Ehlers-Danlos syndrome: Although there has been growing enthusiasm for the therapeutic potential of intranasal oxytocin for addressing a variety of social-emotional difficulties in EDs (e.g., [9]), research has been scarce and the results inconsistent (e.g., [9, 35, 36, 44, 46]).